Pacira BioSciences (PCRX) FCF Margin (2010 - 2026)
Pacira BioSciences' FCF Margin was 29.17% in Q2 2026, up 24.03 percentage points from 5.14% a year earlier and up 16.23 percentage points from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) FCF Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Pacira BioSciences' FCF Margin was 24.06% through Jun 30, 2026, up 7.47 percentage points year-over-year; for FY2025, it was 18.81%, down 6.69 percentage points from FY2024.
- FCF Margin shows a five-year change of +9.68 percentage points (FY2020 to FY2025).
- In earlier years, FCF Margin was 25.50% in FY2024 (+4.84 pp), 20.67% in FY2023 (+3.39 pp), 17.28% in FY2022 (+2.53 pp) and 14.75% in FY2021 (+5.61 pp).
- Quarterly FCF Margin has moved between 5.14% (Q2 2025) and 36.96% (Q3 2021) over five years.
- Compared with a year earlier, FCF Margin was higher in four of the last eight quarters, with an average year-over-year change of -1.38 percentage points.
- The best year-over-year quarter for FCF Margin over five years was Q2 2026 (a gain of 24.03 percentage points); the worst was Q2 2025 (a drop of 23.87 percentage points).
- Per Business Quant data, PCRX's FCF Margin in the three quarters before Q2 2026 was 12.94% (Q1 2026), 22.08% (Q4 2025) and 31.73% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Pacira BioSciences | 1.46 Bn | 468.61 Mn | 139.42 Mn | 26.29% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.29% |
| Jun 30, 2026 | 29.17% |
| Mar 31, 2026 | 12.94% |
| Dec 31, 2025 | 22.08% |
| Sep 30, 2025 | 31.73% |
| Jun 30, 2025 | 5.14% |
| Mar 31, 2025 | 15.93% |
| Dec 31, 2024 | 16.56% |
| Sep 30, 2024 | 29.56% |
| Jun 30, 2024 | 29.01% |
| Mar 31, 2024 | 27.68% |
| Dec 31, 2023 | 25.26% |
| Sep 30, 2023 | 25.04% |
| Jun 30, 2023 | 23.66% |
| Mar 31, 2023 | 7.84% |
| Dec 31, 2022 | 21.25% |
| Sep 30, 2022 | 22.38% |
| Jun 30, 2022 | 10.67% |
| Mar 31, 2022 | 14.63% |
| Dec 31, 2021 | 8.83% |
API Access
Pacira BioSciences FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();